Skip to content

Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.

Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03388671
Acronym
TAB
Enrollment
44
Registered
2018-01-03
Start date
2017-12-25
Completion date
2020-12-31
Last updated
2020-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

The aim of this study will be to investigate the safety and analgesic efficacy of Transversus Abdominis Plane (TAB) Block versus psoas block blockade. Both blocks will be administered surgically and guided by the laparoscopy screen in children undergoing laparoscopic surgery.

Detailed description

Transversus abdominis plane (TAP) block is a promising effective method for postoperative pain control after major abdominal surgery. TAP block provides analgesia by inhibiting nerve conduction from the anterior abdominal wall arising from the intercostal nerves, subcostal nerves, and first lumbar nerve (T6-L1). Using a landmark technique, it is easily performed, but its popularity has decreased because of reduced efficacy due to inaccurate injection and the potential for intra-peritoneal organ damage. Ultrasound-guided TAP block provides better results and fewer complications, but it requires experienced operators. Surgically administered TAP (sTAP) block guided by the video camera of the laparoscope is a simple technique and may cause no complications. Also, under laparoscopic guidance, block of ilioinguinal, iliohypogastric, and genitofemoral nerves can be possible with anesthetic injection in the plane between psoas major and the fasciae covering its anterior aspects \[laparoscopic-assisted psoas (LAP) blockade\].

Interventions

PROCEDURETAB Block

patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided TAB Block

PROCEDUREPsoas Block

patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Psoas Block

DRUGBupivacaine

patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Psoas Block or TAB block

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The data collection personnel and the patients' guardians will be blinded to the group assignment.

Intervention model description

The aim of this study will be to investigate the safety and analgesic efficacy of Transversus Abdominis Plane (TAB) Block versus psoas blocks. Both blocks will be administered surgically and guided by the laparoscopy screen in children undergoing laparoscopic surgery.

Eligibility

Sex/Gender
ALL
Age
1 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* Children (1-6 years) of both sexes undergoing elective laparoscopic surgeries that last \>30minutes (eg. undescended testis and inguinal hernia repair). * Written consent, free and informed

Exclusion criteria

* Significant respiratory, cardiac or renal disease * BMI \>95th percentile for age.

Design outcomes

Primary

MeasureTime frameDescription
FLACC PAIN score36hourspostoperative FLACC pain scores.

Countries

Egypt

Contacts

Primary ContactHala S Abdelghaffar, MD
hallasaad@yahoo.com01003812011
Backup ContactSeham M Moeen, MD
seham.moeen@yahoo.com01006386324

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026